Figure 4

Kaplan-Meier survival analysis of p300 expression in total patients and subsets of different stage patients with HCC (log-rank test). A. Total, probability of survival of all patients with HCC: low expression, n = 63; high expression, n = 60. B. Stage II, probability of survival of stage II patients with HCC: low expression, n = 27; high expression, n = 22. C. Stage III, probability of survival of stage III patients with HCC: low expression, n = 23; high expression, n = 25. D. Stage IV, probability of survival of stage IV patients with HCC: low expression, n = 3; high expression, n = 11. E. Comparison of overall survival according to a new combined clinicopathologic prognostic model (including p300, AFP level and vascular invasion): low risk, n = 70; intermediate risk, n = 29; high risk, n = 24.